TNFRSF17 and B-cell non-Hodgkin lymphoma: CD-19 is a target antigen for B cell acute lymphoblastic leukemia (ALL), B cell non-Hodgkin lymphoma, follicular lymphoma, mantle cell lymphoma (MCL), and B cell maturation antigen (BCMA) targeting against multiple myeloma [58].